Tonix Pharmaceuticals Expands Leadership Team With Appointment Of Joseph Hand, Esq. As General Counsel And EVP Of Operations

Tonix Pharmaceuticals Holding Corp., a fully-integrated biopharmaceutical company with both marketed products and a strong pipeline of development candidates, has announced the appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations. His appointment is effective immediately. Joseph Hand brings extensive leadership experience across several critical areas, including legal affairs, business development, human resources, and information technology operations. His diverse background positions him well to support Tonix’s strategic goals and day-to-day operations.

Before joining Tonix, Mr. Hand spent nearly a decade at Celgene Corporation, where he concluded his tenure as Executive Vice President of Global Human Resources and Corporate Services, as well as a member of the company’s Executive Committee. In this role, he oversaw all employee-related functions, such as talent development, recruitment, and compensation and benefits. He was also responsible for managing Celgene’s global facilities footprint. Importantly, he played a strategic role in several major transactions, including the $74 billion acquisition of Celgene by Bristol Myers Squibb and the $13.4 billion divestiture of Otezla to Amgen.

Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, said in a statement, “Joe’s strong track record of delivering company growth, driving transformative initiatives, and negotiating complex transactions makes him an important strategic addition to the Tonix team at a pivotal inflection point in the Company’s history. The breadth of Joe’s expertise and his focus on operational excellence will serve our mission as we prepare for the launch of TNX-102 SL for the management of fibromyalgia, upon receiving FDA marketing authorization.”

Mr. Hand mentioned, “I’m honored to join Tonix at such an exciting time and grateful for the opportunity to work alongside an incredibly talented and dedicated leadership team and group of employees. I look forward to contributing to the Company’s momentum and helping to position Tonix for long-term growth while advancing our mission to deliver meaningful therapies to patients.”

Following his time at Celgene, Mr. Hand served as Chief Administrative Officer at Phathom Pharmaceuticals. In this role, he was responsible for recruiting over 300 employees across multiple departments and played a key role in building out the company’s commercial sales force. Earlier in his career, Mr. Hand practiced as a litigation attorney at the international law firm Jones Day. He holds a Bachelor of Business Administration from the University of Notre Dame and a Juris Doctor from New York University School of Law.